Medical/Pharmaceuticals
Mentice AB (publ) receives an order of USD 540,000 for simulation solutions from Corewell Health, Grand Rapids, Michigan, USA
GOTHENBURG, Sweden, Dec. 30, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that Corewell Health,Grand Rapids, Michigan USA, has signed an agreement to acquire Mentice VIST® simulation solutions...
2022-12-30 20:53
4168
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19
* GS221 has conducted 3 clinical trials. Current results of clinical trials show favorable safety and tolerance in the subjects. After administration, the patients showed trends of improvement of clinical symptoms, shortening time for negative nucleic acid test, and rapid decline of viral load;...
2022-12-30 13:23
4235
Everest Medicines to Hold New Corporate Strategy Online Conference Calls
SHANGHAI, Dec. 30, 2022 /PRNewswire/ -- Everest Medicines (HKEX: 1952), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced that the Company's management will host conference calls to introduce its new corpora...
2022-12-30 08:05
6193
Everest Medicines Announces China NMPA Recommends Priority Review for Nefecon for the Treatment of Primary IgA Nephropathy
--Further regulatory support for accelerated approval of Nefecon following
NMPA's NDA acceptance with Breakthrough Therapy Designation—
SHANGHAI, Dec. 30, 2022 /PRNewswire/ -- Everest Medicines
2022-12-30 08:00
6709
Takeda Healthcare Philippines Inc Honored the Inspirational Award at the Asia Pacific Enterprise Awards 2022 Regional Edition
SINGAPORE, Dec. 28, 2022 /PRNewswire/ -- Enterprise Asia, the organizer of the Asia Pacific Enterprise Awards (APEA) 2022 Regional Edition, is pleased to recognize 25 exemplary business leaders and enterprises acrossAsia which excelled and showcased unparalleled resilience and growth despite theC...
2022-12-28 15:30
3089
SAVEWO introduces the only Hong Kong-made respirator obtaining top EU and China certifications, enters medical market with increased investment and production capacity
HONG KONG, Dec. 28, 2022 /PRNewswire/ -- While the COVID-19 pandemic stabilises inHong Kong and many resume normal life, Hong Kong-based mask developer and manufacturer SAVEWO plans to increase investment and production capacity, pivoting from masks for the mass to the professional medical grade ...
2022-12-28 11:00
4061
Everest Medicines Commences Operations at its mRNA Vaccine Manufacturing Facility, Accelerating Evolution to a Fully-Integrated Biopharma
--Everest owns complete pharmaceutical and vaccine value chain from discovery, clinical development, manufacturing and commercialization-- --Localizes company's mRNA vaccine production, and helps meet urgent China and global demand for innovative vaccines and medicines-- SHANGHAI, Dec. 28, 2022 ...
2022-12-28 08:00
5069
Non-invasive in vitro diagnostic (IVD) test enables early detection of colorectal cancer
SAO PAULO, Brazil, Dec. 27, 2022 /PRNewswire/ -- The DNA Methylation Detection Kit for Human SDC2, ADHFE1 and PPP2R5C Genes (Real-Time PCR), the colorectal cancer early detection product under BGI's wholly-owned subsidiary BGI Biotechnology (Wuhan) Co., Ltd., has recently obtained the medical dev...
2022-12-27 23:59
2653
Promising Singaporean Medtech Firm Osteopore Achieves Record Revenue, Enters New Markets and Operates in All Major Continents in 2022
SINGAPORE, Dec. 27, 2022 /PRNewswire/ -- Singapore-based Medtech Firm Osteopore announces their record revenue of$460,684 for Q3 CY22, an increase of 6.6% over the preceding quarter. As an extension of the same financial year, Osteopore has likewise broadened their regional operations to spanColo...
2022-12-27 20:37
4963
Brii Biosciences Provides Update on Strategic Clinical Development Progress
Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023 Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical hol...
2022-12-27 20:00
5184
Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification
* Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets * With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India HYDERABAD, India, Dec. 27, ...
2022-12-27 10:00
5279
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies
SHANGHAI, Dec. 27, 2022 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze") announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. ("Yonghe") to develop series of targeted radiopharmaceutical therapy ("TRT") products. Under the...
2022-12-27 10:00
4412
MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity
SHANGHAI and HANGZHOU, China, Dec. 26, 2022 /PRNewswire/ -- MindRank, an artificial intelligence (AI)-empowered drug discovery company, announces today that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for MDR-001, an oral sma...
2022-12-26 23:00
4017
Pulnovo Medical will be attending JPM Healthcare Conference 2023
SHANGHAI, Dec. 24, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovative platform, will be attending the upcoming 41st J.P. Morgan Healthcare Conference 2023 to discuss the latest trends in innovative technologies and development strategies in the medical device secto...
2022-12-24 20:00
4986
Fosun International Granted Three Awards from Global Banking and Finance Review in the United Kingdom
HONG KONG, Dec. 23, 2022 /PRNewswire/ -- On 23 December 2022, Fosun International was notified byGlobal Banking and Finance Review, a famous financial magazine in theUnited Kingdom, that Fosun International was granted three awards, namely "Brand of the Year Awards - Holding Group Brand of the Y...
2022-12-23 10:52
5340
JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL
Best Cell & Gene Therapy Acquisition 2022: Juniper Biologics/Kolon Life Science
SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Singapore-headquartered Juniper
Biologics Pte Ltd
2022-12-23 09:35
3765
Antengene Announces NDA Submission for XPOVIO® in Macau, Malaysia and Thailand for Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-cell Lymphoma
SHANGHAI and HONG KONG, Dec. 23, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hem...
2022-12-23 08:30
4454
P3 Research secures investment from Genesis Capital to accelerate expansion
* P3 is a leading New Zealand clinical trial site network founded in 1998 * With sites in seven locations throughout New Zealand, P3's clients range from large multi-nationals to small biotechs globally * Genesis Capital has become the major shareholder of the clinical trials group alongside...
2022-12-22 19:36
4188
New STIC trial data shows longer overall survival for therapy selection based on CELLSEARCH® CTC count in patients with metastatic breast cancer
Integration of CTC (Circulating Tumor Cell) enumeration* to decide between endocrine therapy and chemotherapy may lead to improved clinical outcomes and quality of life for patients with oestrogen receptor (ER) positive)/human epidermal growth factor receptor (HER) 2 negative metastatic breast ca...
2022-12-22 16:00
5065
Gemini Rosemont adds Peninsula Life Science Center eight-story office building to portfolio in all cash transaction
LOS ANGELES, Dec. 22, 2022 /PRNewswire/ -- Gemini Rosemont Commercial Real
Estate, a vertically integrated real estate investment management firm
specializing in Class A multi-tenant office and luxury residential properties,
has acquired Peninsula Life Science Center for$59,350,000.
2022-12-22 11:27
7576
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 263 media titles]
2026-10-05 11:51Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
9180
DayOne Files Registration Statement for Proposed Initial Public Offering
2026-10-06 05:28
8293
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8265
